Skip to main content
Top
Published in: Diabetologia 8/2005

01-08-2005 | Article

Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins

Authors: M. Lehtovirta, J. Kaprio, L. Groop, M. Trombetta, R. C. Bonadonna

Published in: Diabetologia | Issue 8/2005

Login to get access

Abstract

Aims/hypothesis

The genetic architecture of model-derived parameters of beta cell function has never been assessed. Therefore, we estimated heritability (h 2) for model-derived phenotypes of insulin secretion in twins.

Methods

Thirty-three monozygotic (MZ) and 23 dizygotic (DZ) twin pairs from the Finnish Twin Cohort Study underwent an OGTT (plasma glucose/C-peptide at 0, 30, 60, 90 and 120 min). A subset of the twin pairs (21 MZ/20 DZ) also underwent an IVGTT (frequent sampling of plasma glucose/insulin from 0 to 60 min) followed by a 160-min euglycaemic–hyperinsulinaemic clamp (45 mU·min−1·m−2). Mathematical modelling was applied to the IVGTT and the OGTT to assess first-phase (readily releasable insulin [RRI]) and second-phase (sigma) secretion (IVGTT), and a global index of beta cell performance (OGTT beta index). Intraclass correlation coefficients and genetic and non-genetic components for trait variances were computed to assess the h 2 of model-derived parameters.

Results

The intraclass correlation coefficients in MZ twins were 0.78 for RRI, 0.67 for sigma and 0.57 for OGTT beta index. In DZ twins the correlation coefficients were 0.23, 0.32 and 0.42, respectively. Using the most parsimonious model for each trait, the h 2 – the proportion of variance accounted for by genetic factors – was 76% (95% CI: 53–88%) for RRI, 28% (34–80%) for sigma and 53% (26–72%) for OGTT beta index.

Conclusions/interpretation

Our findings demonstrate that model-derived parameters of insulin secretion have a substantial genetic component and may be used in the search for genetic determinants of beta cell function in humans.
Appendix
Available only for authorised users
Literature
1.
go back to reference Flint J, Mott R (2001) Finding the molecular basis of quantitative traits: successes and pitfalls. Nat Rev Genet 2:437–445 Flint J, Mott R (2001) Finding the molecular basis of quantitative traits: successes and pitfalls. Nat Rev Genet 2:437–445
2.
go back to reference DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and insulin resistance. Am J Physiol 237:E214–E223PubMed DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and insulin resistance. Am J Physiol 237:E214–E223PubMed
3.
go back to reference Radziuk J (2000) Insulin sensitivity and its measurements: structural commonalities among methods. J Clin Endocrinol Metab 85:4426–4433CrossRefPubMed Radziuk J (2000) Insulin sensitivity and its measurements: structural commonalities among methods. J Clin Endocrinol Metab 85:4426–4433CrossRefPubMed
4.
go back to reference Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799–806 Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799–806
5.
go back to reference Mittelman SD, Van Citters GW, Kim SP et al (2000) Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta cell response. Diabetes 49:2116–2125PubMed Mittelman SD, Van Citters GW, Kim SP et al (2000) Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta cell response. Diabetes 49:2116–2125PubMed
6.
go back to reference Henquin J-C, Boitard C, Efendic S, Ferrannini E, Steiner DF, Cerasi E (2002) Editorial. Insulin secretion. Movement at all levels. Diabetes 51(Suppl 1):S1–S2 Henquin J-C, Boitard C, Efendic S, Ferrannini E, Steiner DF, Cerasi E (2002) Editorial. Insulin secretion. Movement at all levels. Diabetes 51(Suppl 1):S1–S2
7.
go back to reference Henquin J-C, Ishiyama N, Nenquin M, Ravier MA, Jonas J-C (2002) Signals and pools underlying biphasic insulin secretion. Diabetes 51(Suppl 1):S60–S67PubMed Henquin J-C, Ishiyama N, Nenquin M, Ravier MA, Jonas J-C (2002) Signals and pools underlying biphasic insulin secretion. Diabetes 51(Suppl 1):S60–S67PubMed
8.
go back to reference Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794PubMed Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794PubMed
9.
go back to reference Tripathy D, Carlsson AL, Lehto M, Isomaa B, Tuomi T, Groop L (2000) Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state. Diabetologia 43:1476–1483CrossRefPubMed Tripathy D, Carlsson AL, Lehto M, Isomaa B, Tuomi T, Groop L (2000) Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state. Diabetologia 43:1476–1483CrossRefPubMed
10.
go back to reference Van Haeften T, Pimenta W, Mitrakou A et al (2000) Relative contributions of beta-cell function and tissue insulin sensitivity to fasting and post glucose-load glycaemia. Metabolism 49:1318–1325CrossRefPubMed Van Haeften T, Pimenta W, Mitrakou A et al (2000) Relative contributions of beta-cell function and tissue insulin sensitivity to fasting and post glucose-load glycaemia. Metabolism 49:1318–1325CrossRefPubMed
11.
go back to reference Bonadonna RC, Stumvoll M, Fritsche A et al (2003) Altered homeostatic adaptation of first- and second-phase beta cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. Diabetes 52:470–480PubMed Bonadonna RC, Stumvoll M, Fritsche A et al (2003) Altered homeostatic adaptation of first- and second-phase beta cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. Diabetes 52:470–480PubMed
12.
go back to reference Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467PubMed Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467PubMed
13.
go back to reference Toffolo G, De Grandi F, Cobelli C (1995) Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of kinetics avoids errors in modelling the secretion. Diabetes 44:845–854PubMed Toffolo G, De Grandi F, Cobelli C (1995) Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of kinetics avoids errors in modelling the secretion. Diabetes 44:845–854PubMed
14.
go back to reference Monauni T, Zenti MG, Cretti A et al (2000) Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes 49:926–935PubMed Monauni T, Zenti MG, Cretti A et al (2000) Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes 49:926–935PubMed
15.
go back to reference Cretti A, Lehtovirta M, Bonora E et al (2001) Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest 31:405–416CrossRefPubMed Cretti A, Lehtovirta M, Bonora E et al (2001) Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest 31:405–416CrossRefPubMed
16.
go back to reference Del Prato S, Marchetti P, Bonadonna RC (2002) Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes (Suppl 1):S109–S116 Del Prato S, Marchetti P, Bonadonna RC (2002) Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes (Suppl 1):S109–S116
17.
go back to reference Lehtovirta M, Kaprio J, Forsblom C, Eriksson J, Tuomilehto J, Groop L (2000) Insulin sensitivity and secretion in monozygotic and dizygotic twins. Diabetologia 43:285–293PubMed Lehtovirta M, Kaprio J, Forsblom C, Eriksson J, Tuomilehto J, Groop L (2000) Insulin sensitivity and secretion in monozygotic and dizygotic twins. Diabetologia 43:285–293PubMed
18.
go back to reference Kaprio J, Sarna S, Koskenvuo M, Rantasalo I (1978) The Finnish Twin Registry: formation and compilation, questionnaire study, zygosity determination procedure, and research program. Prog Clin Biol Res 24:179–184PubMed Kaprio J, Sarna S, Koskenvuo M, Rantasalo I (1978) The Finnish Twin Registry: formation and compilation, questionnaire study, zygosity determination procedure, and research program. Prog Clin Biol Res 24:179–184PubMed
19.
go back to reference Sarna S, Kaprio J, Sistonen P, Koskenvuo M (1978) Diagnosis of twin zygosity by mailed questionnaire. Hum Hered 28:241–254PubMed Sarna S, Kaprio J, Sistonen P, Koskenvuo M (1978) Diagnosis of twin zygosity by mailed questionnaire. Hum Hered 28:241–254PubMed
20.
go back to reference Eriksson J, Franssila-Kallunki A, Ekstrand A et al (1989) Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl J Med 321:337–343PubMed Eriksson J, Franssila-Kallunki A, Ekstrand A et al (1989) Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl J Med 321:337–343PubMed
21.
go back to reference Barrett PH, Bell BM, Cobelli C et al (1998) SAAM II: simulation, analysis, and modelling software for tracer and pharmacokinetic studies. Metabolism 47:484–492CrossRefPubMed Barrett PH, Bell BM, Cobelli C et al (1998) SAAM II: simulation, analysis, and modelling software for tracer and pharmacokinetic studies. Metabolism 47:484–492CrossRefPubMed
22.
go back to reference Polonsky KS, Licinio-Paixao J, Given BD et al (1986) Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest 77:98–105PubMed Polonsky KS, Licinio-Paixao J, Given BD et al (1986) Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest 77:98–105PubMed
23.
go back to reference Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368–377PubMed Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368–377PubMed
24.
go back to reference Neale MC, Cardon LR (1992) Methodology for genetic studies of twins and families. NATO ASI Series. Kluwer Academic Publishers, Dordrecht Neale MC, Cardon LR (1992) Methodology for genetic studies of twins and families. NATO ASI Series. Kluwer Academic Publishers, Dordrecht
25.
go back to reference Posthuma D, Beem AL, de Geus EJC et al (2003) Theory and practice in quantitative genetics. Twin Res 6:361–376CrossRefPubMed Posthuma D, Beem AL, de Geus EJC et al (2003) Theory and practice in quantitative genetics. Twin Res 6:361–376CrossRefPubMed
26.
go back to reference Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automat Contr 19:716–723CrossRef Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automat Contr 19:716–723CrossRef
27.
go back to reference Neale MC, Boker SM, Xie G, Maes HH (2002) Mx: statistical modelling, 6th edn. VCU, Department of Psychiatry, Richmond, VA, USA Neale MC, Boker SM, Xie G, Maes HH (2002) Mx: statistical modelling, 6th edn. VCU, Department of Psychiatry, Richmond, VA, USA
28.
go back to reference Williams CJ, Christian JC, Norton JA Jr (1992) TWINAN90: a Fortran program for conducting ANOVA-based and likelihood-based analyses of twin data. Comput Methods Programs Biomed 38:167–176CrossRefPubMed Williams CJ, Christian JC, Norton JA Jr (1992) TWINAN90: a Fortran program for conducting ANOVA-based and likelihood-based analyses of twin data. Comput Methods Programs Biomed 38:167–176CrossRefPubMed
29.
go back to reference Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W (1993) Additive insulinotropic effects of exogenous synthetic human gastric-inhibitory polypeptide and glucagon-like peptide-1(7–36) amide infused at near-physiological insulinotropic hormone- and glucose concentrations. J Clin Endocrinol Metab 76:912–917CrossRefPubMed Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W (1993) Additive insulinotropic effects of exogenous synthetic human gastric-inhibitory polypeptide and glucagon-like peptide-1(7–36) amide infused at near-physiological insulinotropic hormone- and glucose concentrations. J Clin Endocrinol Metab 76:912–917CrossRefPubMed
30.
go back to reference Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C (2001) Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes 50:150–158PubMed Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C (2001) Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes 50:150–158PubMed
31.
go back to reference Mari A, Schmitz O, Gastaldelli A, Oestergard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for the assessment of beta-cell function: modelling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159–E1166PubMed Mari A, Schmitz O, Gastaldelli A, Oestergard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for the assessment of beta-cell function: modelling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159–E1166PubMed
32.
go back to reference Lindsten J, Cerasi E, Luft R, Morton N, Ryman N (1976) Significance of genetic factors for the plasma insulin response to glucose in healthy subjects. Clin Genet 10:125–134PubMed Lindsten J, Cerasi E, Luft R, Morton N, Ryman N (1976) Significance of genetic factors for the plasma insulin response to glucose in healthy subjects. Clin Genet 10:125–134PubMed
33.
go back to reference Colilla S, Cox NJ, Ehrmann DA (2001) Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab 86:2027–2031CrossRefPubMed Colilla S, Cox NJ, Ehrmann DA (2001) Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab 86:2027–2031CrossRefPubMed
34.
go back to reference Poulsen P, Levin K, Petersen I, Christensen K, Beck-Nielsen H, Vaag A (2005) Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins. Diabetes 54:275–283PubMed Poulsen P, Levin K, Petersen I, Christensen K, Beck-Nielsen H, Vaag A (2005) Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins. Diabetes 54:275–283PubMed
35.
go back to reference Rossetti L, Giaccari A, DeFronzo RA (1990) Glucose toxicity. Diabetes Care 13:610–630PubMed Rossetti L, Giaccari A, DeFronzo RA (1990) Glucose toxicity. Diabetes Care 13:610–630PubMed
36.
go back to reference Bell GI, Polonsky KS (2001) Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 414:788–791CrossRefPubMed Bell GI, Polonsky KS (2001) Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 414:788–791CrossRefPubMed
37.
go back to reference The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197 The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197
38.
go back to reference WHO Consultation Group (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. WHO/NCD/NCS/99.2, Geneva WHO Consultation Group (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. WHO/NCD/NCS/99.2, Geneva
Metadata
Title
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins
Authors
M. Lehtovirta
J. Kaprio
L. Groop
M. Trombetta
R. C. Bonadonna
Publication date
01-08-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 8/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1815-2

Other articles of this Issue 8/2005

Diabetologia 8/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine